

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.69512354 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.69512354 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.34829254 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.34829254 |
| 5 | angiotensin maturation (GO:0002003) | 6.17578576 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.97647062 |
| 7 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.80371435 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.79766337 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 5.66322432 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.21494524 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.17166632 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.05584926 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.05584926 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.05584926 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.99720765 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.98847117 |
| 17 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.97814230 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.92401877 |
| 19 | regulation of cholesterol esterification (GO:0010872) | 4.90990545 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.88604962 |
| 21 | protein carboxylation (GO:0018214) | 4.88270515 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88270515 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.84151544 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.82443728 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.81642550 |
| 26 | intestinal absorption (GO:0050892) | 4.78925934 |
| 27 | cysteine metabolic process (GO:0006534) | 4.73551248 |
| 28 | urea metabolic process (GO:0019627) | 4.71060990 |
| 29 | urea cycle (GO:0000050) | 4.71060990 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.69560148 |
| 31 | phospholipid efflux (GO:0033700) | 4.69020967 |
| 32 | regulation of fibrinolysis (GO:0051917) | 4.67570551 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.65666256 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58306014 |
| 35 | lipoprotein transport (GO:0042953) | 4.52968078 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.52197049 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.52197049 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.52197049 |
| 39 | bile acid metabolic process (GO:0008206) | 4.44199898 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.41885866 |
| 41 | regulation of complement activation (GO:0030449) | 4.39211454 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.32854611 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 4.31052168 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.27636624 |
| 45 | NADH metabolic process (GO:0006734) | 4.25561349 |
| 46 | cholesterol efflux (GO:0033344) | 4.21365613 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.17990054 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.16984444 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.16793987 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.15546592 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.15546592 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.15363160 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.15363160 |
| 54 | drug metabolic process (GO:0017144) | 4.11149967 |
| 55 | lysine metabolic process (GO:0006553) | 4.10902861 |
| 56 | lysine catabolic process (GO:0006554) | 4.10902861 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.10162221 |
| 58 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06660872 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 4.05148823 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.99487954 |
| 61 | diacylglycerol metabolic process (GO:0046339) | 3.99213616 |
| 62 | drug catabolic process (GO:0042737) | 3.98236548 |
| 63 | fructose metabolic process (GO:0006000) | 3.95844243 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 3.94759160 |
| 65 | phospholipid homeostasis (GO:0055091) | 3.93736266 |
| 66 | cellular ketone body metabolic process (GO:0046950) | 3.90317559 |
| 67 | hormone catabolic process (GO:0042447) | 3.84697079 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 3.73529813 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 3.71691149 |
| 70 | protein-lipid complex assembly (GO:0065005) | 3.70696218 |
| 71 | glutamate metabolic process (GO:0006536) | 3.65673620 |
| 72 | cellular glucuronidation (GO:0052695) | 3.65607654 |
| 73 | cholesterol homeostasis (GO:0042632) | 3.62596464 |
| 74 | coenzyme catabolic process (GO:0009109) | 3.62465514 |
| 75 | plasma lipoprotein particle organization (GO:0071827) | 3.62116900 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 3.61272969 |
| 77 | amine catabolic process (GO:0009310) | 3.61235851 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 3.61235851 |
| 79 | sterol homeostasis (GO:0055092) | 3.58120350 |
| 80 | negative regulation of lipase activity (GO:0060192) | 3.55014155 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.55013154 |
| 82 | fibrinolysis (GO:0042730) | 3.53589648 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.52999733 |
| 84 | drug transmembrane transport (GO:0006855) | 3.50396845 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50336099 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50336099 |
| 87 | virion attachment to host cell (GO:0019062) | 3.50042912 |
| 88 | adhesion of symbiont to host cell (GO:0044650) | 3.50042912 |
| 89 | lipoprotein metabolic process (GO:0042157) | 3.49826551 |
| 90 | ethanol oxidation (GO:0006069) | 3.47978235 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.47957736 |
| 92 | adhesion of symbiont to host (GO:0044406) | 3.47308885 |
| 93 | protein activation cascade (GO:0072376) | 3.46430755 |
| 94 | protein-lipid complex subunit organization (GO:0071825) | 3.44888415 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.44055722 |
| 96 | omega-hydroxylase P450 pathway (GO:0097267) | 3.43364293 |
| 97 | complement activation (GO:0006956) | 3.41957760 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.40288624 |
| 99 | exogenous drug catabolic process (GO:0042738) | 3.40263393 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.39216393 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.38904708 |
| 102 | cofactor catabolic process (GO:0051187) | 3.38066922 |
| 103 | organic acid catabolic process (GO:0016054) | 3.37628380 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.37628380 |
| 105 | serine family amino acid metabolic process (GO:0009069) | 3.37563894 |
| 106 | ketone body metabolic process (GO:1902224) | 3.37071865 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.34122441 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.32644161 |
| 109 | urate metabolic process (GO:0046415) | 3.32643878 |
| 110 | arginine metabolic process (GO:0006525) | 3.32486755 |
| 111 | ethanol metabolic process (GO:0006067) | 3.32288102 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.32150204 |
| 113 | uronic acid metabolic process (GO:0006063) | 3.32150204 |
| 114 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.30913452 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 3.30652001 |
| 116 | fatty acid oxidation (GO:0019395) | 3.29983318 |
| 117 | glycosphingolipid catabolic process (GO:0046479) | 3.26846402 |
| 118 | negative regulation of blood coagulation (GO:0030195) | 3.26121674 |
| 119 | negative regulation of hemostasis (GO:1900047) | 3.26121674 |
| 120 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.25892751 |
| 121 | endocrine process (GO:0050886) | 3.25892751 |
| 122 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.25892751 |
| 123 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.25035229 |
| 124 | acute-phase response (GO:0006953) | 3.23398152 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 3.20623730 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 3.20373446 |
| 127 | transcytosis (GO:0045056) | 3.19890608 |
| 128 | blood coagulation, intrinsic pathway (GO:0007597) | 3.16786975 |
| 129 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.15767925 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 3.12239551 |
| 131 | glycolipid catabolic process (GO:0019377) | 3.09614779 |
| 132 | peptide catabolic process (GO:0043171) | 3.05092903 |
| 133 | negative regulation of coagulation (GO:0050819) | 3.03856367 |
| 134 | regulation of guanylate cyclase activity (GO:0031282) | 2.99028193 |
| 135 | renal system process involved in regulation of blood volume (GO:0001977) | 2.93262956 |
| 136 | regulation of cholesterol metabolic process (GO:0090181) | 2.87973380 |
| 137 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.87638649 |
| 138 | low-density lipoprotein particle clearance (GO:0034383) | 2.87272754 |
| 139 | positive regulation of steroid metabolic process (GO:0045940) | 2.86112745 |
| 140 | L-ascorbic acid metabolic process (GO:0019852) | 2.84444244 |
| 141 | negative regulation of wound healing (GO:0061045) | 2.79952530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.89541147 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.14658806 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.08460925 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77171742 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.54001911 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.79786315 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.54988062 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.02858951 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45736539 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.11248542 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07795265 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.06753770 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93625953 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73619790 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70428526 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62882638 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61993669 |
| 18 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.61080143 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57232844 |
| 20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57081799 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.57044985 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56025220 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41728012 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38966427 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24202610 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24177008 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23750723 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22593304 |
| 29 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21957640 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21463393 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19309790 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18339029 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17357539 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16350796 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16035060 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15860568 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15006746 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11686060 |
| 39 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07730066 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07040035 |
| 41 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04676083 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04332433 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04135224 |
| 44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02319518 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00982622 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00715241 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98591392 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97857950 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97774485 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97774485 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95431873 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94735306 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94517583 |
| 54 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93390899 |
| 55 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93047372 |
| 56 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.91753932 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91029002 |
| 58 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89179211 |
| 59 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86778561 |
| 60 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85923524 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83918974 |
| 62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83531942 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83390252 |
| 64 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82878717 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82006557 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81209283 |
| 67 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80979017 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.79881171 |
| 69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79473356 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79172326 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77047926 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75907642 |
| 73 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.72832390 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.72191093 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71811092 |
| 76 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71327003 |
| 77 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.71104023 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.70218510 |
| 79 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.70212048 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.70164811 |
| 81 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.69693899 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69013762 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67926500 |
| 84 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67425322 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.67160018 |
| 86 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.66581044 |
| 87 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66249354 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 0.64582561 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.63814487 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63691201 |
| 91 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.63256586 |
| 92 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62514385 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62282305 |
| 94 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61017135 |
| 95 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60722752 |
| 96 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.60266515 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.58843634 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58798219 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.58752577 |
| 100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58072607 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57250944 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.57239575 |
| 103 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56217765 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.55692368 |
| 105 | CBP_21632823_ChIP-Seq_H3396_Human | 0.53924960 |
| 106 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52873089 |
| 107 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52777173 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52213941 |
| 109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.51444125 |
| 110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.51444125 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.51297043 |
| 112 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.51202111 |
| 113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.50295150 |
| 114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.50283769 |
| 115 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.50215528 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.49907767 |
| 117 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49778804 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.49345879 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.49291191 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.48263537 |
| 121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.47786372 |
| 122 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47550114 |
| 123 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.47245311 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47220657 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46596029 |
| 126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.46392249 |
| 127 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.46189256 |
| 128 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.46164841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.14685208 |
| 2 | MP0005360_urolithiasis | 6.71540617 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.48964242 |
| 4 | MP0005365_abnormal_bile_salt | 5.38196720 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.53622210 |
| 6 | MP0009840_abnormal_foam_cell | 3.92096419 |
| 7 | MP0003252_abnormal_bile_duct | 3.53852385 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41759780 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.22954113 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.97920226 |
| 11 | MP0005083_abnormal_biliary_tract | 2.74558234 |
| 12 | MP0005332_abnormal_amino_acid | 2.65785702 |
| 13 | MP0003195_calcinosis | 2.65174529 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.62610834 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.61714290 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.38408942 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.08067751 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.07456545 |
| 19 | * MP0000609_abnormal_liver_physiology | 2.05894160 |
| 20 | MP0010368_abnormal_lymphatic_system | 2.02297981 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 1.76304765 |
| 22 | MP0003303_peritoneal_inflammation | 1.67702000 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.67582098 |
| 24 | MP0010155_abnormal_intestine_physiology | 1.65163808 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.64907253 |
| 26 | MP0005409_darkened_coat_color | 1.58322850 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57982915 |
| 28 | MP0003724_increased_susceptibility_to | 1.56249651 |
| 29 | MP0002254_reproductive_system_inflammat | 1.53290122 |
| 30 | MP0003690_abnormal_glial_cell | 1.52986818 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.51788783 |
| 32 | MP0000604_amyloidosis | 1.47860337 |
| 33 | MP0003868_abnormal_feces_composition | 1.45269257 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.39632982 |
| 35 | MP0005670_abnormal_white_adipose | 1.38663328 |
| 36 | MP0001764_abnormal_homeostasis | 1.33799527 |
| 37 | MP0003879_abnormal_hair_cell | 1.27103402 |
| 38 | MP0004147_increased_porphyrin_level | 1.25451023 |
| 39 | MP0003011_delayed_dark_adaptation | 1.21517948 |
| 40 | MP0003186_abnormal_redox_activity | 1.20146226 |
| 41 | MP0005451_abnormal_body_composition | 1.19624765 |
| 42 | MP0009764_decreased_sensitivity_to | 1.14392707 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.11157690 |
| 44 | MP0009697_abnormal_copulation | 1.10796618 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.10215462 |
| 46 | MP0000598_abnormal_liver_morphology | 1.09218803 |
| 47 | MP0008469_abnormal_protein_level | 1.07166513 |
| 48 | MP0009785_altered_susceptibility_to | 1.06896289 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.05782126 |
| 50 | MP0004130_abnormal_muscle_cell | 1.05535717 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.05426346 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.04870371 |
| 53 | * MP0009763_increased_sensitivity_to | 1.00792342 |
| 54 | MP0006054_spinal_hemorrhage | 0.97328600 |
| 55 | MP0003866_abnormal_defecation | 0.97242315 |
| 56 | * MP0005636_abnormal_mineral_homeostasis | 0.96187973 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 0.90836437 |
| 58 | MP0009642_abnormal_blood_homeostasis | 0.89865606 |
| 59 | MP0001664_abnormal_digestion | 0.89131633 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 0.85295997 |
| 61 | MP0002998_abnormal_bone_remodeling | 0.84831901 |
| 62 | MP0001756_abnormal_urination | 0.84318867 |
| 63 | MP0005647_abnormal_sex_gland | 0.83802148 |
| 64 | MP0003329_amyloid_beta_deposits | 0.82205843 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.81152973 |
| 66 | MP0004858_abnormal_nervous_system | 0.79848315 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.79697661 |
| 68 | MP0003075_altered_response_to | 0.78216764 |
| 69 | MP0005408_hypopigmentation | 0.78170000 |
| 70 | MP0002971_abnormal_brown_adipose | 0.76909814 |
| 71 | MP0006082_CNS_inflammation | 0.76601958 |
| 72 | MP0005334_abnormal_fat_pad | 0.74113341 |
| 73 | * MP0005025_abnormal_response_to | 0.74098479 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.73884172 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.72281116 |
| 76 | MP0005023_abnormal_wound_healing | 0.71732301 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.71663730 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.71537058 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.70500354 |
| 80 | MP0003436_decreased_susceptibility_to | 0.70480413 |
| 81 | MP0000477_abnormal_intestine_morphology | 0.70119265 |
| 82 | MP0001661_extended_life_span | 0.70100484 |
| 83 | MP0005535_abnormal_body_temperature | 0.70040042 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.68408055 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.67895797 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.67159094 |
| 87 | MP0001790_abnormal_immune_system | 0.66984448 |
| 88 | MP0005387_immune_system_phenotype | 0.66984448 |
| 89 | MP0001663_abnormal_digestive_system | 0.66081543 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 0.63981506 |
| 91 | MP0000249_abnormal_blood_vessel | 0.63324238 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.63087790 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.63012937 |
| 94 | MP0000566_synostosis | 0.62850383 |
| 95 | MP0004043_abnormal_pH_regulation | 0.62381025 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.61489255 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.60956652 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.60927204 |
| 99 | MP0005164_abnormal_response_to | 0.60434430 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.60314315 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.59436176 |
| 102 | MP0000538_abnormal_urinary_bladder | 0.59359716 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.58466503 |
| 104 | MP0002419_abnormal_innate_immunity | 0.58274975 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.57625774 |
| 106 | MP0008004_abnormal_stomach_pH | 0.56605795 |
| 107 | MP0006036_abnormal_mitochondrial_physio | 0.54944215 |
| 108 | MP0004883_abnormal_blood_vessel | 0.54596221 |
| 109 | MP0005448_abnormal_energy_balance | 0.54475052 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.54353690 |
| 111 | MP0000920_abnormal_myelination | 0.53544787 |
| 112 | MP0003633_abnormal_nervous_system | 0.53003150 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.52709810 |
| 114 | MP0004947_skin_inflammation | 0.52189501 |
| 115 | MP0003172_abnormal_lysosome_physiology | 0.51770826 |
| 116 | MP0005166_decreased_susceptibility_to | 0.51590692 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.51553389 |
| 118 | MP0000858_altered_metastatic_potential | 0.51167882 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.50949527 |
| 120 | MP0008873_increased_physiological_sensi | 0.49070123 |
| 121 | MP0008874_decreased_physiological_sensi | 0.45285791 |
| 122 | MP0009115_abnormal_fat_cell | 0.44592301 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.43896246 |
| 124 | MP0002090_abnormal_vision | 0.43361836 |
| 125 | MP0001243_abnormal_dermal_layer | 0.42161440 |
| 126 | MP0002928_abnormal_bile_duct | 0.41588410 |
| 127 | MP0003953_abnormal_hormone_level | 0.41320977 |
| 128 | MP0005165_increased_susceptibility_to | 0.40697922 |
| 129 | MP0000343_altered_response_to | 0.40382949 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.40115076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.60733539 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.34674001 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.18068765 |
| 4 | Xanthomatosis (HP:0000991) | 5.94286401 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.65321023 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.51283291 |
| 7 | Complement deficiency (HP:0004431) | 5.49114656 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.17343729 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.94863514 |
| 10 | Joint hemorrhage (HP:0005261) | 4.65737622 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.33748787 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.18923479 |
| 13 | Hypoalphalipoproteinemia (HP:0003233) | 4.17141236 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.13050997 |
| 15 | Hyperammonemia (HP:0001987) | 4.06675358 |
| 16 | Abnormality of complement system (HP:0005339) | 4.05694402 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.04160101 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01164901 |
| 19 | Epidermoid cyst (HP:0200040) | 3.93391865 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.91330280 |
| 21 | Ketosis (HP:0001946) | 3.90243813 |
| 22 | Fat malabsorption (HP:0002630) | 3.68917325 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68520200 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.68273538 |
| 25 | Hyperglycinuria (HP:0003108) | 3.65467822 |
| 26 | Glomerulonephritis (HP:0000099) | 3.63407283 |
| 27 | Hyperglycinemia (HP:0002154) | 3.62386469 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.60294099 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.60294099 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54435147 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.52671224 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.46324800 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44553610 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20018055 |
| 35 | Myocardial infarction (HP:0001658) | 3.09906850 |
| 36 | Ketoacidosis (HP:0001993) | 3.08331921 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.05310253 |
| 38 | Widely patent fontanelles and sutures (HP:0004492) | 2.96078612 |
| 39 | Vascular calcification (HP:0004934) | 2.86739549 |
| 40 | Hyperbilirubinemia (HP:0002904) | 2.86643470 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 2.85982227 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83514738 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.78579759 |
| 44 | Skin nodule (HP:0200036) | 2.75377529 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.74623982 |
| 46 | Steatorrhea (HP:0002570) | 2.70182522 |
| 47 | Amyloidosis (HP:0011034) | 2.68152998 |
| 48 | Nausea (HP:0002018) | 2.65478546 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.62580633 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.59448490 |
| 51 | Cardiovascular calcification (HP:0011915) | 2.56349373 |
| 52 | Facial shape deformation (HP:0011334) | 2.55774093 |
| 53 | Potter facies (HP:0002009) | 2.55774093 |
| 54 | Purpura (HP:0000979) | 2.54351122 |
| 55 | Pigmentary retinal degeneration (HP:0001146) | 2.53116968 |
| 56 | Abnormality of vitamin metabolism (HP:0100508) | 2.52088366 |
| 57 | Gout (HP:0001997) | 2.50772194 |
| 58 | Ileus (HP:0002595) | 2.49235659 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.48156481 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44536155 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.44536155 |
| 62 | Metabolic acidosis (HP:0001942) | 2.43701902 |
| 63 | Esophageal varix (HP:0002040) | 2.42034034 |
| 64 | Axonal loss (HP:0003447) | 2.41688545 |
| 65 | Nephritis (HP:0000123) | 2.39650001 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39528617 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39528617 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39528617 |
| 69 | Abnormality of serum amino acid levels (HP:0003112) | 2.39003452 |
| 70 | Late onset (HP:0003584) | 2.34986630 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33863486 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.33863486 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.33163072 |
| 74 | Hypophosphatemia (HP:0002148) | 2.33040100 |
| 75 | Spontaneous abortion (HP:0005268) | 2.32100764 |
| 76 | Nonimmune hydrops fetalis (HP:0001790) | 2.32089983 |
| 77 | Flat acetabular roof (HP:0003180) | 2.29541274 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.27173823 |
| 79 | Chronic diarrhea (HP:0002028) | 2.26573419 |
| 80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.23732847 |
| 81 | Irritability (HP:0000737) | 2.23434342 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21343970 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21343970 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21343970 |
| 85 | Wide cranial sutures (HP:0010537) | 2.20530411 |
| 86 | Mitral stenosis (HP:0001718) | 2.20493786 |
| 87 | Lethargy (HP:0001254) | 2.19028672 |
| 88 | Acanthocytosis (HP:0001927) | 2.18102043 |
| 89 | Neurofibrillary tangles (HP:0002185) | 2.18013729 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 2.16121666 |
| 91 | Hydroxyprolinuria (HP:0003080) | 2.16121666 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14174635 |
| 93 | Abnormality of urine glucose concentration (HP:0011016) | 2.12320944 |
| 94 | Pancreatitis (HP:0001733) | 2.12198183 |
| 95 | Malnutrition (HP:0004395) | 2.12170105 |
| 96 | Alkalosis (HP:0001948) | 2.11217302 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.07926078 |
| 98 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.06474612 |
| 99 | Hypotension (HP:0002615) | 2.05975636 |
| 100 | Hyperactive renin-angiotensin system (HP:0000841) | 2.05663042 |
| 101 | Confusion (HP:0001289) | 2.05084901 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.04071041 |
| 103 | Rickets (HP:0002748) | 2.03703309 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.02707960 |
| 105 | Cholecystitis (HP:0001082) | 2.02707960 |
| 106 | Abnormal tarsal ossification (HP:0008369) | 2.01434296 |
| 107 | Gingival bleeding (HP:0000225) | 2.01385369 |
| 108 | Abnormality of carpal bone ossification (HP:0006257) | 2.00682127 |
| 109 | Thin bony cortex (HP:0002753) | 2.00241168 |
| 110 | Abdominal distention (HP:0003270) | 1.99767308 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96965367 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.96881406 |
| 113 | Cholelithiasis (HP:0001081) | 1.96615138 |
| 114 | Proximal tubulopathy (HP:0000114) | 1.96313527 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.95868200 |
| 116 | Spastic diplegia (HP:0001264) | 1.95101084 |
| 117 | Thrombophlebitis (HP:0004418) | 1.94991445 |
| 118 | Eczematoid dermatitis (HP:0000976) | 1.94518329 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 1.93327660 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92570450 |
| 121 | Vomiting (HP:0002013) | 1.92102299 |
| 122 | Metabolic alkalosis (HP:0200114) | 1.91525878 |
| 123 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91521380 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.91360067 |
| 125 | Abnormality of vitamin B metabolism (HP:0004340) | 1.91320373 |
| 126 | Symptomatic seizures (HP:0011145) | 1.90763045 |
| 127 | Menorrhagia (HP:0000132) | 1.89173353 |
| 128 | Nephrolithiasis (HP:0000787) | 1.88662110 |
| 129 | Hyperuricemia (HP:0002149) | 1.87007545 |
| 130 | Increased purine levels (HP:0004368) | 1.87007545 |
| 131 | Enlarged kidneys (HP:0000105) | 1.86114593 |
| 132 | Peripheral demyelination (HP:0011096) | 1.82659947 |
| 133 | Elevated alkaline phosphatase (HP:0003155) | 1.81668778 |
| 134 | Neonatal onset (HP:0003623) | 1.80752187 |
| 135 | Glycosuria (HP:0003076) | 1.80292860 |
| 136 | Metaphyseal irregularity (HP:0003025) | 1.79773483 |
| 137 | Protuberant abdomen (HP:0001538) | 1.76821915 |
| 138 | Joint swelling (HP:0001386) | 1.75343111 |
| 139 | Decreased circulating renin level (HP:0003351) | 1.75187251 |
| 140 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74007567 |
| 141 | Pulmonary embolism (HP:0002204) | 1.72838315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 5.27103947 |
| 2 | BCKDK | 4.72351097 |
| 3 | ACVR1B | 4.42746131 |
| 4 | ERN1 | 4.00622876 |
| 5 | TIE1 | 3.26645839 |
| 6 | TGFBR2 | 3.26066540 |
| 7 | SIK1 | 3.09295174 |
| 8 | INSRR | 3.00184195 |
| 9 | FGFR4 | 2.99906575 |
| 10 | DDR2 | 2.64635857 |
| 11 | TAOK3 | 2.39989778 |
| 12 | EPHB1 | 2.19211345 |
| 13 | TYK2 | 2.05124223 |
| 14 | BLK | 1.98297863 |
| 15 | PDGFRA | 1.78311331 |
| 16 | PRPF4B | 1.71008908 |
| 17 | MST1R | 1.70768611 |
| 18 | TRIB3 | 1.61519249 |
| 19 | PTK6 | 1.58589823 |
| 20 | JAK1 | 1.55609179 |
| 21 | PIK3CG | 1.52391282 |
| 22 | ICK | 1.50830849 |
| 23 | MAPK15 | 1.43161148 |
| 24 | CDC42BPA | 1.42469665 |
| 25 | JAK2 | 1.39378095 |
| 26 | PKN2 | 1.38375883 |
| 27 | EPHA2 | 1.37968894 |
| 28 | MATK | 1.36568050 |
| 29 | CAMK1D | 1.35651236 |
| 30 | FRK | 1.34265315 |
| 31 | NEK9 | 1.29432663 |
| 32 | TBK1 | 1.23812991 |
| 33 | MET | 1.23271712 |
| 34 | IRAK3 | 1.23172693 |
| 35 | AKT3 | 1.18857434 |
| 36 | TYRO3 | 1.18186596 |
| 37 | FLT3 | 1.17501023 |
| 38 | ERBB4 | 1.16835920 |
| 39 | MAPK11 | 1.14983018 |
| 40 | FGFR2 | 1.12445080 |
| 41 | MAPK12 | 1.06652028 |
| 42 | MAP2K4 | 1.05641140 |
| 43 | PRKAA2 | 1.05527094 |
| 44 | MAP3K14 | 1.04936336 |
| 45 | DAPK2 | 1.04291657 |
| 46 | MAP2K2 | 0.95470761 |
| 47 | GRK1 | 0.92372963 |
| 48 | MAP2K3 | 0.89155552 |
| 49 | MYLK | 0.87621876 |
| 50 | WNK4 | 0.87032682 |
| 51 | CAMK1G | 0.86821795 |
| 52 | GSK3A | 0.86553430 |
| 53 | MAP3K10 | 0.85097072 |
| 54 | RIPK1 | 0.84825340 |
| 55 | CSK | 0.84561821 |
| 56 | RIPK4 | 0.84264810 |
| 57 | MAP3K3 | 0.83154573 |
| 58 | TESK2 | 0.83120808 |
| 59 | STK24 | 0.82737645 |
| 60 | LMTK2 | 0.80870920 |
| 61 | ABL2 | 0.79230358 |
| 62 | FGR | 0.78424054 |
| 63 | TESK1 | 0.78117365 |
| 64 | TAOK1 | 0.77188174 |
| 65 | KSR2 | 0.75894099 |
| 66 | MAP3K7 | 0.74884641 |
| 67 | LATS1 | 0.74711708 |
| 68 | MAP2K6 | 0.73495256 |
| 69 | EPHA3 | 0.72890920 |
| 70 | CSF1R | 0.72150819 |
| 71 | TAOK2 | 0.71788236 |
| 72 | MAPK4 | 0.70267011 |
| 73 | EPHA4 | 0.70103537 |
| 74 | PINK1 | 0.68496199 |
| 75 | IGF1R | 0.67389520 |
| 76 | NLK | 0.66382161 |
| 77 | EPHB2 | 0.65558772 |
| 78 | PDPK1 | 0.65044913 |
| 79 | EEF2K | 0.64871791 |
| 80 | GRK7 | 0.64508396 |
| 81 | MAP3K12 | 0.63797687 |
| 82 | MAPK7 | 0.63566518 |
| 83 | SGK494 | 0.63054566 |
| 84 | SGK223 | 0.63054566 |
| 85 | PTK2 | 0.62637947 |
| 86 | MAP3K2 | 0.60844162 |
| 87 | GRK6 | 0.59498331 |
| 88 | IKBKE | 0.58151677 |
| 89 | MAPKAPK3 | 0.57737264 |
| 90 | OXSR1 | 0.56784368 |
| 91 | PRKACG | 0.56065927 |
| 92 | RET | 0.54577853 |
| 93 | CAMK4 | 0.54058432 |
| 94 | MAP2K1 | 0.53180552 |
| 95 | MAP3K1 | 0.53073812 |
| 96 | SRC | 0.52526646 |
| 97 | PRKD1 | 0.52323198 |
| 98 | ITK | 0.52081605 |
| 99 | PKN1 | 0.51900848 |
| 100 | ERBB2 | 0.51590952 |
| 101 | STK39 | 0.50176784 |
| 102 | PRKG2 | 0.48410377 |
| 103 | TGFBR1 | 0.47855820 |
| 104 | FGFR3 | 0.47601991 |
| 105 | PRKCZ | 0.47432070 |
| 106 | SGK3 | 0.47325615 |
| 107 | CDK6 | 0.47207524 |
| 108 | EGFR | 0.47081566 |
| 109 | PDK2 | 0.46744571 |
| 110 | PDK1 | 0.46119690 |
| 111 | DYRK1B | 0.46119646 |
| 112 | PDGFRB | 0.44896571 |
| 113 | JAK3 | 0.44291346 |
| 114 | CAMKK2 | 0.44229296 |
| 115 | ZAP70 | 0.43635747 |
| 116 | LATS2 | 0.43353746 |
| 117 | PAK4 | 0.43211992 |
| 118 | PRKAA1 | 0.43120971 |
| 119 | PIM2 | 0.42923829 |
| 120 | NTRK1 | 0.42435241 |
| 121 | FYN | 0.42294054 |
| 122 | CAMK2G | 0.41838836 |
| 123 | BMPR2 | 0.41810700 |
| 124 | PRKCQ | 0.41460299 |
| 125 | KIT | 0.40177107 |
| 126 | MAP3K5 | 0.39058769 |
| 127 | CAMK2D | 0.37514657 |
| 128 | YES1 | 0.36507477 |
| 129 | LYN | 0.36505800 |
| 130 | PRKCA | 0.34744051 |
| 131 | PIK3CA | 0.32255168 |
| 132 | MAP3K11 | 0.31391063 |
| 133 | WNK3 | 0.31176903 |
| 134 | IRAK1 | 0.30853153 |
| 135 | FER | 0.29428657 |
| 136 | IRAK2 | 0.29266290 |
| 137 | MAP4K1 | 0.29073077 |
| 138 | PRKCD | 0.26392194 |
| 139 | MAP3K13 | 0.25383707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.97576569 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.93684020 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22562466 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85176804 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.80365539 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80086766 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69683529 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54863255 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48526210 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42054385 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.36440335 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.27843035 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25483580 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23133891 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11338571 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09258903 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04202831 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.01873550 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00039186 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94272187 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88034910 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82777162 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79985267 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77862178 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71264427 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70207322 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63038585 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.58571511 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53682803 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51767514 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48591162 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48332479 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44714556 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43694963 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42234137 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.40574414 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40028918 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36275977 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31235870 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31203706 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29534266 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26301476 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22709000 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21586618 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19374950 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13722154 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13317632 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12289980 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02417713 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97001308 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94274347 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91440041 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90066994 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88016198 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83230840 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82532988 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78103729 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.73025528 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72826379 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.69092595 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66227863 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64299139 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59735947 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55519599 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53843890 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50676979 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45702793 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.44914402 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44108392 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.43876936 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.42288403 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40330790 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39492516 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38100323 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32424054 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32222521 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31275034 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30886652 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30820362 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29154137 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.28981120 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28161682 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.27162715 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26916525 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24901489 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.24499193 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24050701 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.23260774 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.20398192 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.19904675 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19427329 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18595795 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.16302199 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16251813 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16246127 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.14659327 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.14312688 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.12121120 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.11224107 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10702054 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.10500524 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06901447 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.06335645 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.05879875 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04133732 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03963712 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.03841176 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02032555 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01019766 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00509622 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1319163 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1282685 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1177952 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0955735 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0852348 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | -0.0803161 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0619458 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0289736 |

